[{"Assets_0_Q2_USD":153816000.0,"CommonStockSharesOutstanding_0_Q2_shares":31553672.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-13242000.0,"NetIncomeLoss_2_Q2_USD":-16505000.0,"NetIncomeLoss_1_Q2_USD":-6461000.0,"StockholdersEquity_0_Q2_USD":150036000.0,"Ticker":"REPL","CIK":"1737953","name":"REPLIMUNE GROUP, INC.","OfficialName":"Replimune Group Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"857797433.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181114"}]